Chronic oral infection with major periodontal bacteria Tannerella forsythia modulates systemic atherosclerosis risk factors and inflammatory markers

Pathogens and Disease

Volumn 73, Issue 3, 2015, Pages

  Chukkapalli, Sasanka S ^a   Rivera Kweh, Mercedes F ^a   Velsko, Irina M ^a   Chen, Hao ^b   Zheng, Donghang ^b   Bhattacharyya, Indraneel ^a   Gangula, Pandu R ^c   Lucas, Alexandra R ^b   Kesavalu, Lakshmyya ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c School of Medicine and School of Dentistry   (United States)

Author keywords

ApoEnull; Atheromatous plaque; Atherosclerosis; Periodontal disease; Tannerella forsythia

Indexed keywords

ACUTE PHASE PROTEIN; EOTAXIN; EOTAXIN 2; FAS LIGAND; FRACTALKINE; GAMMA INTERFERON; GENOMIC DNA; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 9; LEPTIN; LIPOPROTEIN; LYMPHOTACTIN; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; RANTES; SERUM AMYLOID A; STROMAL CELL DERIVED FACTOR 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ATHEROSCLEROSIS; AORTIC TISSUE; ARTERIAL WALL THICKNESS; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CD3+ T LYMPHOCYTE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMORAL IMMUNITY; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; MIXED INFECTION; MOUSE; MOUTH CAVITY; MOUTH INFECTION; MOUTH PLAQUE; NONHUMAN; PERIODONTAL DISEASE; PRIORITY JOURNAL; RISK FACTOR; TANNERELLA FORSYTHIA; TH17 CELL; ALVEOLAR BONE LOSS; ANIMAL; ATHEROSCLEROSIS; BACTEREMIA; BACTEROIDETES; BLOOD; CHRONIC DISEASE; COMPLICATION; GRAM NEGATIVE INFECTION; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; MALE; MICROBIOLOGY; PATHOLOGY;

ALVEOLAR BONE LOSS; ANIMALS; ANTIBODIES, BACTERIAL; ATHEROSCLEROSIS; BACTEREMIA; BACTEROIDETES; CHRONIC DISEASE; GRAM-NEGATIVE BACTERIAL INFECTIONS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLAMMATION; LIPOPROTEINS; MALE; MICE; MICE, KNOCKOUT; NITRIC OXIDE; PERIODONTAL DISEASES; RISK FACTORS; SERUM AMYLOID A PROTEIN;

EID: 84938115244     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1093/femspd/ftv009     Document Type: Article

References (67)

1. Bahekar AA, Singh S, Saha S, et al. The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am Heart J 2007;154:830-7.
2. Bainbridge B, Verma RK, Eastman C, et al. Role of Porphyromonas gingivalis phosphoserine phosphatase enzyme SerB in inflammation, immune response, and induction of alveolar Bone resorption in rats. Infect Immun 2010;78:4560-9.
3. Bartee MY, Dai E, Liu L, et al. 10 M-T7: measuring chemokinemodulating activity. Method Enzymol 2009;460:209-28.
4. Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroentero 2011;9:88-96.
5. Channon KM, Qian H, George SE. Nitric oxide synthase in atherosclerosis and vascular injury: insights from experimental gene therapy. Arterioscl Thromb Vas 2000;20:1873-81.
6. Chukkapalli SS, Rivera MF, Velsko IM, et al. Invasion of oral and aortic tissues by oral spirochete Treponema denticola in ApoE(-/-) mice causally links periodontal disease and atherosclerosis. Infect Immun 2014;82:1959-67.
7. Dai E, Liu LY, Wang H, et al. Inhibition of chemokineglycosaminoglycan interactions in donor tissue reduces mouse allograft vasculopathy and transplant rejection. PLoS One 2010;5:e10510.
8. Dashper SG, Seers CA, Tan KH, et al. Virulence factors of the oral spirochete Treponema denticola. J Dent Res 2011;90:691-703.
9. Forner L, Larsen T, Kilian M, et al. Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. J Clin Periodontol 2006;33:401-7.
10. Frias-Lopez J, Duran-Pinedo A. Effect of periodontal pathogens on the metatranscriptome of a healthy multispecies biofilm model. J Bacteriol 2012;194:2082-95.
11. Friedewald VE, Kornman KS, Beck JD, et al. The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: periodontitis and atherosclerotic cardiovascular disease. Am J Cardiol 2009;104:59-68.
12. Gibson FC, Hong C, Chou H-H, et al. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004;109:2801-6.
13. Grenier D. Characterization of the trypsin-like activity of Bacteroides-Forsythus. Microbiology 1995;141:921-6.
14. Hajishengallis G, Lamont RJ. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD)model of periodontal disease etiology. Mol Oral Microbiol 2012;27:409-19.
15. Hajishengallis G, Liang S, Payne MA, et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 2011;10:497-506.
16. Haraszthy VI, Zambon JJ, Trevisan M, et al. Identification of periodontal pathogens in atheromatous plaques. J Periodontol 2000;71:1-7.
17. Hasebe A, Yoshimura A, Into T, et al. Biological activities of Bacteroides forsythus lipoproteins and their possible pathological roles in periodontal disease. Infect Immun 2004;72:1318-25.
18. Hayashi C, Gudino CV, Gibson FC, III, et al. Pathogen-induced inflammation at sites distant from oral infection: bacterial persistance and induction of cell-specific innate immune inflammatory pathways. Mol Oral Microbiol 2010;25:305-16.
19. Honda K, Littman DR. The microbiome in infectious disease and inflammation. Annu Rev Immunol 2012;30:759-95.
20. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science 2012;336:1268-73.
21. Hughes CV, Malki G, Loo CY, et al. Cloning and expression of alpha-d-glucosidase and N-acetyl-beta-glucosaminidase from the periodontal pathogen, Tannerella forsythensis (Bacteroides forsythus). Oral Microbiol Immunol 2003;18:309-12.
22. Humphrey LL, Fu R, Buckley DI, et al. Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis. J Gen Intern Med 2008;23:2079-86.
23. Ikegami A, Honma K, Sharma A, et al. Multiple functions of the leucine-rich repeat protein LrrA of Treponema denticola. Infect Immun 2004;72:4619-27.
24. Iwai T. Periodontal bacteremia and various vascular diseases. J Periodontal Res 2009;44:689-94.
25. Jenkinson HF, Lamont RJ. Oral microbial communities in sickness and in health. Trends Microbiol 2005;13:589-95.
26. Kamada N, Seo SU, Chen GY, et al. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 2013;13:321-35.
27. Kataoka H, Murakami R, Numaguchi Y, et al. Angiotensin II type 1 receptor blockers prevent tumor necrosis factor-alphamediated endothelial nitric oxide synthase reduction and superoxide production in human umbilical vein endothelial cells. Eur J Pharmacol 2010;636:36-41.
28. Kebschull M, Demmer RT, Papapanou PN. 'Gum bug, leave my heart alone!-' epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis. J Dent Res 2010;89:879-902.
29. Kesavalu L, Lucas AR, Verma RK, et al. Increased atherogenesis during Streptococcus mutans infection in ApoE-null mice. J Dent Res 2012;91:255-60.
30. Kesavalu L, Sathishkumar S, Bakthavatchalu V, et al. Rat model of polymicrobial infection, immunity, and alveolar bone resorption in periodontal disease. Infect Immun 2007;75: 1704-12.
31. Kozarov E, Sweier D, Shelburne C, et al. Detection of bacterial DNA in atherornatous plaques by quantitative PCR. Microbes Infect 2006;8:687-93.
32. Kumon Y, Suehiro T, Hashimoto K, et al. Local expression of acute phase serum amyloid A mRNA in rheumatoid arthritis synovial tissue and cells. J Rheumatol 1999;26:785-90.
33. Lalla E, Lamster IB, Hofmann MA, et al. Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 2003;23:1405-11.
34. Lee H-R, Jun H-K, Choi B-K. Tannerella forsythia BspA increases the risk factors for atherosclerosis in ApoE(-/-) mice. Oral Dis 2013;8:803-8.
35. Li L, Messas E, Batista EL, et al. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 2002;105:861-7.
36. Lockhart PB, Bolger AF, Papapanou PN, et al. Periodontal disease and atherosclerotic vascular disease: Does the evidence support an independent association?: A scientific statement from the American Heart Association. Circulation 2012;125:2520-44.
37. Lucas A, Liu L, Macen J, et al. Virus-encoded serine proteinase inhibitor SERP-1 inhibits atherosclerotic plaque development after balloon angioplasty. Circulation 1996;94: 2890-900.
38. Matthys KE, Bult H. Nitric oxide function in atherosclerosis. Mediat Inflamm 1997;6:3-21.
39. Meek RL, Urieli-Shoval S, Benditt EP. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. P Natl Acad Sci USA 1994;91: 3186-90.
40. Meredith IT, Anderson TJ, Uehata A, et al. Role of endothelium in ischemic coronary syndromes. Am J Cardiol 1993;72:27C-31C.
41. Miyamoto T, Yumoto H, Takahashi Y, et al. Pathogen-accelerated atherosclerosis occurs early after exposure and can be prevented via immunization. Infect Immun 2006;74: 1376-80.
42. Murakami Y, Higuchi N, Nakamura H, et al. Bacteroides forsythus hemagglutinin is inhibited by N-acetylneuraminyllactose. Oral Microbiol Immunol 2002;17:125-8.
43. Mustapha IZ, Debrey S, Oladubu M, et al. Markers of systemic bacterial exposure in periodontal disease and cardiovascular disease risk: a systematic review and meta-analysis. J Periodontol 2007;78:2289-302.
44. Nahid MA, Rivera M, Lucas A, et al. Polymicrobial infection with periodontal pathogens specifically enhances microRNAmiR-146a in ApoE-/-mice during experimental periodontal disease. Infect Immun 2011;79:1597-605.
45. Nonnenmacher C, Stelzel M, Susin C, et al. Periodontal microbiota in patients with coronary artery disease measured by real-time polymerase chain reaction: a case-control study. J Periodontol 2007;78:1724-30.
46. Paquette DW, Brodala N, Nichols TC. Cardiovascular disease, inflammation, and periodontal infection. Periodontol 2000 2007;44:113-26.
47. Paster BJ, Boches SK, Galvin JL, et al. Bacterial diversity in human subgingival plaque. J Bacteriol 2001;183:3770-83.
48. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005;366:1809-20.
49. Rivera MF, Lee JY, Aneja M, et al. Polymicrobial infection with major periodontal pathogens induced periodontal disease and aortic atherosclerosis in hyperlipidemic ApoE(null) mice. PLoS One 2013;8:e57178.
50. Rudney JD, Chen R, Sedgewick GJ. Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythensis are components of a polymicrobial intracellular flora within human buccal cells. J Dent Res 2005;84:59-63.
51. Saito T, Ishihara K, Kato T, et al. Cloning, expression, and sequencing of a protease gene fromBacteroides forsythus ATCC 43037 in Escherichia coli. Infect Immun 1997;65:4888-91.
52. Sakakibara J, Nagano K, Murakami Y, et al. Loss of adherence ability to human gingival epithelial cells in S-layer protein-deficient mutants of Tannerella forsythensis. Microbiology 2007;153:866-76.
53. Sarkar J, McHardy IH, Simanian EJ, et al. Transcriptional responses of Treponema denticola to other oral bacterial species. PLoS One 2014;9:e88361.
54. Settem RP, El-Hassan AT, Honma K, et al. Fusobacterium nucleatum and Tannerella forsythia induce synergistic alveolar bone loss in a mouse periodontitis model. Infect Immun 2012a;80:2436-43.
55. Settem RP, Honma K, Nakajima T, et al. A bacterial glycan core linked to surface (S)-layer proteins modulates host immunity through Th17 suppression. Mucosal Immunol 2012b;6: 415-26.
56. Sharma A. Virulence mechanisms of Tannerella forsythia. Periodontol. 2000 2010;54:106-16.
57. Sharma A, Inagaki S, Honma K, et al. Tannerella forsythia-induced alveolar bone loss in mice involves leucine-rich-repeat BspA protein. J Dent Res 2005;84:462-7.
58. Sharma A, Sojar HT, Glurich I, et al. Cloning, expression, and sequencing of a cell surface antigen containing a leucine-rich repeat motif from Bacteroides forsythus ATCC 43037. Infect Immun 1998;66:5703-10.
59. Socransky SS, Haffajee AD, Cugini MA, et al. Microbial complexes in subgingival plaque. J Clin Periodontol 1998;25:134-44.
60. Sunde PT, Olsen I, Göbel UB, et al. Fluorescence in situ hybridization (FISH) for direct visualization of bacteria in periapical lesions of asymptomatic root-filled teeth. Microbiology 2003;149:1095-102.
61. Tan KH, Seers CA, Dashper SG, et al. Porphyromonas gingivalis and Treponema denticola exhibit metabolic symbioses. PLoS Pathog 2014;10:e1003955.
62. Thompson H, Homer KA, Rao S, et al. An orthologue of Bacteroides fragilis NanH is the principal sialidase in Tannerella forsythia. J Bacteriol 2009;191:3623-8.
63. Velsko IM, Chukkapalli SS, Rivera MF, et al. Active invasion of oral and aortic tissues by Porphyromonas gingivalis in mice causally links periodontitis and atherosclerosis. PLoS One 2014;9:e97811.
64. Verma RK, Bhattacharyya I, Sevilla A, et al. Virulence of major periodontal pathogens and lack of humoral immune protection in a rat model of periodontal disease. Oral Dis 2010a;16:686-95.
65. Verma RK, Rajapakse S, Meka A, et al. Porphyromonas gingivalis and Treponema denticola mixed microbial infection in a rat model of periodontal disease. Interdiscip Perspect Infect Dis 2010b;2010:605125.
66. Yan G, You B, Chen S-P, et al. Tumor necrosis factor-alpha downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-alpha 1. Circ Res 2008;103:591-7.
67. Zelkha SA, Frielich RW, Amar S. Periodontal innate immune mechanisms relevant to atherosclerosis and obesity. Periodontol 2000 2010;54:207-21.